Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- WOCKPHARMA.NSE
- Price
- 1438.35
- Stock movement down
- -9.55 (-0.66%)
- Company name
- Wockhardt Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 233.69B
- Ent value
- 271.01B
- Price/Sales
- 7.92
- Price/Book
- 6.29
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 12.88%
- 1 year return
- 145.58%
- 3 year return
- 66.48%
- 5 year return
- 41.22%
- 10 year return
- 1.98%
Last updated: 2025-04-03
DIVIDENDS
WOCKPHARMA.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 212.45 |
| Price to FCF | 212.45 |
| Price to EBITDA | 519.31 |
| EV to EBITDA | 602.25 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.92 |
| Price to Book | 6.29 |
| EV to Sales | 9.19 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 162.47M |
| EPS (TTM) | -19.24 |
| FCF per share (TTM) | 7.35 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 29.49B |
| Gross profit (TTM) | 13.14B |
| Operating income (TTM) | 650.00M |
| Net income (TTM) | -2.88B |
| EPS (TTM) | -19.24 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 44.56% |
| Operating margin (TTM) | 2.20% |
| Profit margin (TTM) | -9.77% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.43B |
| Net receivables | 0.00 |
| Total current assets | 20.08B |
| Goodwill | 9.91B |
| Intangible assets | 14.57B |
| Property, plant and equipment | 0.00 |
| Total assets | 75.88B |
| Accounts payable | 6.77B |
| Short/Current long term debt | 23.43B |
| Total current liabilities | 23.80B |
| Total liabilities | 38.75B |
| Shareholder's equity | 37.13B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 1.10B |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 1.10B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -7.76% |
| Return on Assets | -3.80% |
| Return on Invested Capital | -6.11% |
| Cash Return on Invested Capital | 2.33% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1461.75 |
| Daily high | 1463.05 |
| Daily low | 1420.10 |
| Daily Volume | 265K |
| All-time high | 2125.90 |
| 1y analyst estimate | 450.00 |
| Beta | 1.51 |
| EPS (TTM) | -19.24 |
| Dividend per share | - |
| Ex-div date | 17 Nov 2016 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| WOCKPHARMA.NSE | S&P500 | |
| Current price drop from All-time high | -32.34% | -7.90% |
| Highest price drop | -92.98% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -60.18% | -11.07% |
| Avg time to new high | 125 days | 12 days |
| Max time to new high | 2987 days | 1805 days |
COMPANY DETAILS
Marketcap
233.69B
Marketcap category
Large-cap
Description
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company provides contract manufacturing services. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Employees
2386
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found